A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021
GHDx Entry last modified on: Mar 14, 2022
COVID-19
Dataset Records for COVID-19
Displaying 51 - 100 of 1121
Second round statewide survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India. Preprint
GHDx Entry last modified on: May 12, 2022
IgG Antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals might need just one vaccine dose
GHDx Entry last modified on: Mar 14, 2022
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study
GHDx Entry last modified on: May 12, 2022
Covid-19 Vaccination Strategy In Spain
Estrategia De Vacunación Covid-19 En Espana
United States - COVID-19 Reported Patient Impact and Hospital Capacity by Facility
COVID-19 Reported Patient Impact and Hospital Capacity by Facility
Epi surveillance:
Health facility
United States - COVID-19 Diagnostic Laboratory Testing (PCR Testing) Time Series
Epi surveillance:
Health facility - Subnationally representative
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint
GHDx Entry last modified on: May 12, 2022
United States - COVID-19 Reported Patient Impact and Hospital Capacity by State Timeseries
Epi surveillance:
Health facility - Subnationally representative
South Africa COVID-19 Special Public Health Surveillance Bulletin, Volume 18 Supplementary Issue 9, 12 March 2021
COVID-19 Special Public Health Surveillance Bulletin Volume 18 (Issue 9: 12 Mar 2021)
Epi surveillance:
Cross-sectional - Individual
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
33.98% of Tripura has COVID-19 antibody in them, shows sero survey
Survey:
Epi surveillance
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint
GHDx Entry last modified on: May 12, 2022
Australia Household Impacts of Covid-19 Survey November 2020
Insights into the prevalence and nature of impacts from COVID-19 on households in Australia - Round 4
Canada - British Columbia COVID-19 Situation Report Weekly Bulletin
British Columbia (BC) COVID-19 Situation Report
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares -
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020
Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER)
Survey:
Epi surveillance
India - Haryana Covid-19 Sero Survey Round 2, October 2020
Sero-prevalence of Anti-SARS-CoV-2 IgG antibodies in Haryana, India: A Population based Cross-Sectional Study (2nd Round)
Survey:
Cross-sectional - Epi surveillance - Urban-rural representative
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1
ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION
Seroprevalence in Tamil Nadu through India’s two COVID waves: Evidence on antibody decline following infection and vaccination. Preprint
GHDx Entry last modified on: May 12, 2022
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 4 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October
GHDx Entry last modified on: May 12, 2022
Bhutan Royal Centre for Disease Control Quarterly Disease Surveillance Bulletin: Fourth Quarter, October-December 2020
RCDC Surveillance Bullletin, Volume 24, 4th Quarter 2020 (1st Quarter to 30 December) 2020
Epi surveillance:
Subnationally representative
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares -
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany – a cross sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
C''garh: 5.5 pc people have COVID-19 antibodies, says sero survey
Survey:
Cross-sectional - Epi surveillance - Individual
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint
GHDx Entry last modified on: May 12, 2022
Andhra Pradesh Sero Survey Show Nearly 20% of State’s Population Exposed to Covid-19
Survey:
Cross-sectional - Epi surveillance - Urban only
Sweden - Uppsala First Wave COVID-19 ICU Patient Cohort Admitted Mar-Aug 2020, 3-6 Month Follow-up Sept-Nov 2020
Survey:
Health facility - Individual - Interview - Longitudinal
20% of Andhra Exposed to Covid, Sero-survey Finds, Exposure Highest Where Case Tally Lowest
Survey:
Cross-sectional - Epi surveillance - Urban only
India - Jharkhand Regional Outreach Bureau Twitter Communications and COVID-19 Updates
GHDx Entry last modified on: Feb 10, 2022
Mexico - Yucatán Under-5 Endline Household Survey 2020
Survey:
Cross-sectional - Household - Individual - Interview
Canada COVID-19 Seroprevalence in Ontario: September 3 to October 30, 2020
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares -
Kolkata: One in Four People Have Covid Antibodies
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Quelimane (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Quelimane (InCOVID 2020) - Resultados Preliminares -
Canada COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020
COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020
About 10 million people have been infected with the Corona virus in Afghanistan
حدود ده ملیون تن در افغانستان به ویروس کرونا مبتلا شده اند
Press Briefing: Sero Survey Delhi
Survey:
Cross-sectional - Urban only
United States - Washington Hospitalized or Ambulatory Adults with Respiratory Viral Infections 2020
HAARVI
Survey:
Health facility - Longitudinal - Outpatient
Over 56% of Delhi has Covid-19 Antibodies: Health Minister Satyendar Jain on 5th Serosurvey
Survey:
Urban only
India - Haryana Covid -19 Sero Survey Round 1, August 2020
Sero-prevalence of anti-SARS-CoV-2 IgG antibodies in Haryana, India: a Population-Based Cross Sectional Study
Survey:
Epi surveillance
Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria. Preprint
Scientific literature:
Epi surveillance
29.1% people in Delhi developed antibodies against COVID-19, finds latest sero-survey
GHDx Entry last modified on: Feb 10, 2022
Assam's Sero-survey found 23.7 per cent Seroprevalence in the State
Survey:
Epi surveillance
Subscribe